Related Experiment Video
Updated: Apr 20, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Could elevated platelet-lymphocyte ratio predict left ventricular systolic dysfunction in patients with non-ST
Adem Bekler1, Emine Gazi, Mustafa Yılmaz
1Department of Cardiology, Faculty of Medicine, Çanakkale Onsekiz Mart University; Çanakkale-Turkey. adembekler27@gmail.com.
Insights
A high platelet-lymphocyte ratio (PLR) independently predicts left ventricular systolic dysfunction (LVSD) in patients with non-ST elevated acute coronary syndrome (NST-ACS). This finding offers a simple biomarker for assessing cardiac risk in these patients.
Area of Science:
- Cardiology
- Biomarkers
- Acute Coronary Syndromes
Background:
- The platelet-lymphocyte ratio (PLR) has shown prognostic value in non-ST elevated myocardial infarction (NSTEMI) and various cancers.
- Left ventricular systolic dysfunction (LVSD) is a critical complication following acute coronary syndromes.
- Predictive markers for LVSD in non-ST elevated acute coronary syndrome (NST-ACS) are essential for risk stratification.
Purpose of the Study:
- To investigate the predictive value of the platelet-lymphocyte ratio (PLR) for left ventricular systolic dysfunction (LVSD).
- To assess the association between a high PLR and the presence of LVSD in patients diagnosed with NST-ACS.
Main Methods:
- A cohort of 220 patients with NST-ACS was analyzed.
- Patients were stratified into tertiles based on admission PLR values, with high PLR defined as >135.6.
- LVSD was defined as an ejection fraction ≤ 40%, and logistic regression analysis was employed.
Main Results:
- The high PLR group exhibited older age, higher rates of previous myocardial infarction and NSTEMI, and more narrowed coronary arteries.
- Patients with high PLR had significantly lower left ventricular ejection fraction, higher platelet counts, and lower lymphocyte and triglyceride levels.
- A PLR >135.6 was identified as an independent predictor of systolic dysfunction in multivariate analyses (β: 0.306, p=0.001).
Conclusions:
- Elevated platelet-lymphocyte ratio (PLR) is a significant and independent predictor of left ventricular systolic dysfunction (LVSD).
- High PLR serves as a valuable prognostic biomarker for identifying patients with NST-ACS at risk of developing LVSD.
Objective:
The prognostic value of a high platelet-lymphocyte ratio (PLR) has been reported in patients with non-ST elevated myocardial infarction (NSTEMI) and different oncologic disorders. We aimed to evaluate the predictive value of the PLR for left ventricular systolic dysfunction (LVSD) in patients with non-ST elevated acute coronary syndrome (NST-ACS).
Methods:
A total of 220 patients with NST-ACS were included in the study. The study population was divided into tertiles based on admission PLR values. High (n=73) and low PLR (n=147) groups were defined as patients having values in the third tertile (>135.6) and lower 2 tertiles (≤ 135.6), respectively. Left ventricular dysfunction was defined as ejection fraction ≤ 40%, and related variables were evaluated by backward conditional binary logistic regression analysis.
Results:
The patients in the high PLR group were older (p<0.001) and had a higher rate of previous myocardial infarction and NSTEMI (p=0.046, p=0.013, respectively). There were significantly more coronary arteries narrowed (p=0.001) and lower left ventricular ejection fraction (p<0.001) in the high PLR group. Baseline platelet levels were significantly higher (p<0.001) and triglyceride and lymphocyte levels were significantly lower (p=0.009 and p<0.001, respectively) in the high PLR group. PLR >135.6 was found to be an independent predictor of systolic dysfunction in the multivariate analyses (β: 0.306, 95% confidence interval: 0.151-0.619; p=0.001).
Conclusion:
A high PLR is a strong and independent predictor for LVSD in patients with NST-ACS.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

